[1]
Sheldon, H., Duncan, N., Singh, A., Endrizzi, S., Conrardy, R., Brazauskas, R. and Peppard, W. 2024. Naloxone coprescribing best practice advisory for patients at high risk for opioid-related adverse events. Journal of Opioid Management. 20, 6 (Dec. 2024), 471–486. DOI:https://doi.org/10.5055/jom.0866.